Restructuring the Group through M&A and Subsidiary Mergers
First written in FY2017-Q1. 21 of 32 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2027-H1.
27 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「As part of these efforts, during the interim consolidated accounting period the company acquired a pharmaceutical wholesaling business in Saga Prefecture. Going forward, it will continue to expand its business base by leveraging M&A and other means.」
The company acquired a pharmaceutical wholesaling business in Saga Prefecture and is expanding its group structure and business base by leveraging M&A and other means. - FY2026AdvancedAnnual report
「Meanwhile, the Group also worked to reorganise the Group, which had expanded rapidly through M&A, and strengthen internal controls. In the pharmaceutical wholesale business, the core Group subsidiary 株式会社メディカル一光 absorbed 株式会社佐藤薬品販売 and 株式会社若松薬品, its subsidiaries (sub-subsidiaries of the Company), in March 2025, and 京葉沢井薬品株式会社 in June of the same year. In addition, 高知第一薬品株式会社 and 株式会社サイト薬品, which became subsidiaries during the consolidated fiscal year, merged with 株式会社メディカル一光 in September 2025 and December of the same year, respectively.」
The 5 companies 佐藤薬品販売, 若松薬品, 京葉沢井薬品, 高知第一薬品 and サイト薬品 were absorbed into the core subsidiary, advancing the post-M&A Group reorganisation and strengthening internal controls. - FY2026-H1AdvancedAnnual report
「In the previous consolidated fiscal year, 株式会社佐藤薬品販売 and 株式会社若松薬品, which had been consolidated subsidiaries, merged with 株式会社メディカル一光 on 1 March 2025, while 京葉沢井薬品株式会社 merged with it on 1 June 2025. As a result, they were excluded from the scope of consolidation.」
佐藤薬品販売, 若松薬品 and 京葉沢井薬品 merged into メディカル一光, and the scope of consolidation was reorganised. - FY2025AdvancedAnnual report
「As described above, during the consolidated fiscal year, the Group laid steady groundwork for building an even stronger business foundation across the Group by pursuing proactive M&A in all 3 of its core businesses, namely dispensing pharmacies, healthcare and pharmaceutical wholesaling, and driving expansion in scale.」
The Group carried out M&A in all 3 core businesses—dispensing pharmacies, healthcare and pharmaceutical wholesaling—and advanced the reorganisation and expansion of its Group structure and business foundation. - FY2025-H1AdvancedAnnual report
「In April 2024, in the healthcare business, the Group decided that its subsidiary (sub-subsidiary), 株式会社メディカルケア一光, would acquire the care services business of 共創未来メディカルケア株式会社, which operates care services in Tokyo, and completed the acquisition in July of the same year. In May of the same year, in the dispensing pharmacy business, 株式会社メディカル一光, a subsidiary of the Company, decided to acquire all shares of 株式会社京寿薬品, which operates 4 dispensing pharmacies in southern Kyoto Prefecture, and made it a consolidated subsidiary of the Company (sub-subsidiary) in June of the same year. In addition, in July of the same year, 株式会社メディカル一光 entered into a basic agreement with the shareholders of 株式会社佐藤薬品販売 and 株式会社若松薬品 on the acquisition of all shares of both companies, which have operating bases in Saitama and Chiba prefectures, and Kagawa and Tokushima prefectures, respectively, in the pharmaceutical wholesale business.」
The acquisition of the care services business in Tokyo and the conversion of 京寿薬品 into a subsidiary were completed, and basic agreements were also signed for the acquisition of all shares of 2 pharmaceutical wholesalers. M&A-driven Group reorganisation progressed across the dispensing pharmacy, healthcare and pharmaceutical wholesale businesses. - FY2025-Q1AdvancedAnnual report
「In April 2024, in the healthcare business, the Group decided that its non-consolidated subsidiary (sub-subsidiary), 株式会社メディカルケア一光, would acquire the care services business of 共創未来メディカルケア株式会社, which operates care services in Tokyo. This was the Group's first care services transaction in Tokyo. In May of the same year, in the dispensing pharmacy business, 株式会社メディカル一光, a consolidated subsidiary of the Company, acquired all shares of 株式会社京寿薬品, which operates multiple dispensing pharmacies in southern Kyoto Prefecture, and decided to make it a consolidated subsidiary of the Company (sub-subsidiary). Both businesses were to be operated by the Group from the second quarter of the fiscal year.」
The Group decided to acquire the care services business in Tokyo and all shares of 京寿薬品, which operates dispensing pharmacies in southern Kyoto Prefecture, making it a subsidiary, thereby advancing the Group reorganisation. Both businesses were scheduled to begin operations from the second quarter, and operations following completion had not yet commenced. - FY2024-Q3AdvancedAnnual report
「The consolidated subsidiary 株式会社メディカル一光 acquired all shares of 株式会社沖縄アメル on 1 September 2023, making it a consolidated subsidiary.」
株式会社メディカル一光 acquired all shares of 株式会社沖縄アメル on 1 September 2023, advancing the reorganisation of the Group structure in the pharmaceutical wholesale business. - FY2024-Q2AchievedAnnual report
「At a meeting of the Company's Board of Directors held on 31 July 2023, it resolved that its consolidated subsidiary, 株式会社メディカル一光, would acquire the wholesale business for pharmaceuticals and quasi-drugs of 西部沢井薬品株式会社, and the parties entered into a business transfer agreement on the same date. The target business was acquired on 1 September 2023.」
The acquisition of 西部沢井薬品's wholesale business for pharmaceuticals and quasi-drugs was completed on 1 September 2023 following the execution of the business transfer agreement. - FY2024-Q1AdvancedAnnual report
「On 19 April 2023, the Company decided to begin discussions toward integrating its business, centred on the wholesale business for pharmaceuticals, quasi-drugs and other products, with 西部沢井薬品株式会社.」
There was new progress in the reorganisation of the Group structure and business operations, with the decision to begin discussions with 西部沢井薬品 on integrating the wholesale pharmaceuticals business and related operations. A final agreement had not yet been reached. - FY2023-Q3RestatedAnnual report
「In the dispensing pharmacy business, 2 sub-subsidiaries were consolidated under the core subsidiary 株式会社メディカル一光 in March 2022, promoting the integration of business operations and greater management efficiency.」
The Group continues to describe the reorganisation that integrated 山梨薬剤センター and 大豊薬品 into メディカル一光 in March 2022, as well as the subsequent integration of business operations and management efficiencies. - FY2023-Q1AchievedAnnual report
「株式会社山梨薬剤センター and 大豊薬品株式会社, which had been consolidated subsidiaries, merged on 1 March 2022, with the consolidated subsidiary 株式会社メディカル一光 as the surviving company.」
The merger integrating 山梨薬剤センター and 大豊薬品 into メディカル一光 was completed on 1 March 2022, resulting in a reorganisation of the Group structure. - FY2021-Q3AchievedAnnual report
「Happine Life Ikko Co., Ltd., a consolidated subsidiary of the company, resolved at its board meeting held on 30 September 2020 to acquire all shares of Life Care Co., Ltd. and make it a subsidiary, and acquired the shares effective 1 November 2020.」
Regarding the acquisition of all shares of ライフケア, the acquisition was completed on 1 November 2020, making it a subsidiary. - FY2021-Q2AdvancedAnnual report
「Happine Life Ikko Co., Ltd., a consolidated subsidiary of the company, resolved to acquire all shares of Life Care Co., Ltd. and make it a subsidiary, and entered into a share transfer agreement on 30 September 2020. Life Care Co., Ltd. operates 14 residential care facilities and other care businesses, including day-care services, in Aichi Prefecture. The business combination date was scheduled for 1 November 2020, and the voting interest to be acquired was 100%.」
Happine Life Ikko progressed to signing a share transfer agreement for the acquisition of all shares of Life Care. The plan was to make the company, which operates 14 facilities, a 100%-owned subsidiary on 1 November 2020. - FY2021-Q1AdvancedAnnual report
「Medicare Support Co., Ltd. and Tsurukame Dispensing Pharmacy Yugen Kaisha, formerly consolidated subsidiaries, merged effective 1 March 2020, with consolidated subsidiary Medical Ikko Co., Ltd. as the surviving company. At the beginning of the first quarter of the current consolidated accounting period, part of the business of the company's consolidated subsidiary Happine Life Ikko Co., Ltd. was transferred through a company split to Healthcare Capital Co., Ltd., also a consolidated subsidiary.」
In addition to the merger of Medicare Support and Tsurukame Dispensing Pharmacy, the company advanced restructuring by transferring part of Happine Life Ikko's business to Healthcare Capital through a company split. In connection with this, the rental real estate management business was transferred to the real estate business. - FY2020-Q2AdvancedAnnual report
「On 1 April 2019, the company established Medical Ikko Split Preparation Company Co., Ltd., which was included in the scope of consolidation. It changed its corporate name to Medical Ikko Co., Ltd. effective 1 September 2019.」
The company is advancing group restructuring by including in the scope of consolidation the company established to prepare for the transition to a holding-company structure. - FY2019RestatedAnnual report
「Of the above, Effer Co., Ltd. was included in the scope of consolidation because it became a subsidiary during the current consolidated fiscal year. Medicine Ikko Co., Ltd., formerly a consolidated subsidiary, was excluded from the scope of consolidation because it merged with the company.」
The company confirmed the change in the group structure resulting from making Effer a subsidiary and merging Medicine Ikko as a change in the scope of consolidation. - FY2019-Q3RestatedAnnual report
「The company acquired all shares of Effer Co., Ltd. effective 1 March 2018 and made it a subsidiary. Medicine Ikko Co., Ltd. merged effective 1 March 2018, with the company as the surviving company.」
The company continues to describe the change in the group structure resulting from making Effer Co., Ltd. a subsidiary and absorbing Medicine Ikko Co., Ltd. in a merger as a change among affiliated companies. - FY2019-Q2RestatedAnnual report
「The company acquired all shares of Effer Co., Ltd. effective 1 March 2018 and made it a subsidiary. Medicine Ikko Co., Ltd. merged effective 1 March 2018, with the company as the surviving company.」
The company continues to describe the change in the group structure resulting from making Effer Co., Ltd. a subsidiary and absorbing Medicine Ikko Co., Ltd. in a merger as a change among affiliated companies as of the second quarter of the current fiscal year. - FY2019-Q1AdvancedAnnual report
「The company acquired all shares of Effer Co., Ltd. effective 1 March 2018 and made it a subsidiary. Medicine Ikko Co., Ltd. merged effective 1 March 2018, with the company as the surviving company.」
The company acquired all shares of Effer Co., Ltd. and made it a subsidiary, while Medicine Ikko Co., Ltd. was absorbed in a merger effective 1 March 2018, further changing the group structure. - FY2018RestatedAnnual report
「In the healthcare business, the company merged its consolidated subsidiaries Healthcare Ikko Co., Ltd. and Happine Life Care Co., Ltd. in September 2017, changed the corporate name to Happine Life Ikko Co., Ltd. and pursued greater management efficiency.」
The company continues to describe group restructuring and greater management efficiency through the merger and corporate name change involving Healthcare Ikko and Happine Life Care. - FY2018-Q3AdvancedAnnual report
「Healthcare Ikko Co., Ltd. and Happine Life Care Co., Ltd. merged effective 1 September 2017, with Healthcare Ikko Co., Ltd. as the surviving company, and changed the corporate name to Happine Life Ikko Co., Ltd.」
In addition to the merger of existing subsidiaries, the company carried out group restructuring by merging Healthcare Ikko and Happine Life Care effective 1 September 2017 and changing the corporate name to Happine Life Ikko. - FY2018-Q2RestatedAnnual report
「Care Staff Co., Ltd. and Happine Company Yugen Kaisha, formerly consolidated subsidiaries, merged effective 1 March 2017, with consolidated subsidiary Happine Life Care Co., Ltd. as the surviving company.」
The merger of Care Staff Co., Ltd. and Happine Company Yugen Kaisha into Happine Life Care Co., Ltd. continues to be described as a change in the group structure. - FY2018-Q1AdvancedAnnual report
「Care Staff Co., Ltd. and Happine Company Yugen Kaisha, formerly consolidated subsidiaries, merged effective 1 March 2017, with consolidated subsidiary Happine Life Care Co., Ltd. as the surviving company.」
In addition to existing subsidiary mergers, acquisitions and disposals, the company carried out group restructuring by integrating Care Staff and Happine Company into Happine Life Care effective 1 March 2017. - FY2017-Q3AdvancedAnnual report
「In September 2016, the company made Welfare Co., Ltd., which operates group homes and day-care services, a group company. Meanwhile, in November, it sold all shares of Satsuki Co., Ltd., which operates home-visit care and in-home care support services.」
In addition to the merger of existing subsidiaries and the acquisition of Tsurukame Dispensing Pharmacy, the company made Welfare a subsidiary and sold all shares of Satsuki, advancing the restructuring of the group. - FY2017-Q2AdvancedAnnual report
「The company acquired all shares of Tsurukame Dispensing Pharmacy Yugen Kaisha effective 1 August 2016 and made it a subsidiary.」
In addition to the merger of existing subsidiaries, the company made progress in group restructuring by making Tsurukame Dispensing Pharmacy a wholly owned subsidiary effective 1 August 2016. - FY2017-Q1First statedAnnual report
「Bonbon Yugen Kaisha, formerly a consolidated subsidiary, merged effective 1 March 2016, with consolidated subsidiary Medicare Support Co., Ltd. as the surviving company.」
The company carried out a merger between subsidiaries, restructuring the group's business organization.